1ESC Congress 2005: The European society of cardiology launches women at heart. Publishied online. (2005-03- 17). http://www. Medicalnewstoday. com
2Villareal RP, Woodruff AL, Massumi A. Gender and cardiac arrhythmias. Tex Heart Inst J, 2001, 28: 265-275.
3Cotreau MM, Von Moltke LL, Greenblatt DJ, et al. The influence of age and sex on the clearance of cytochrome P450 3A substrates. Clin Pharmacokinet, 2005, 44 : 33-60.
4Harvey PJ, Morris BL, Miller JA, et al. Estradiol induces discordant angiotensin and blood pressure responses to orthostasis in healthy post menopausal women. Hypertension, 2005, 45:399-405.
5Vree TB, Dammers E, Ulc I, et al. Lack of male-famale differences in disposition and esterase hydrolysis of ramipril in healthy volunteers after a single oral dose. SciWorld J, 2003, 3:1332-1343.
6Shekelle PG, Rich MW, Morton SC, et al. Efficacy of angiotensin-converting enzyme inhibitors and beta- blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status. J Am Coll Cardiol, 2003,41:1529-1538.
7Kam KW, Qi JS, cardiac injury and Chen M, et al. expression of Estrogen reduces β1-addrenoceptor upon ischemic insult in the rat heart. Pharmacol Exp Ther, 2004, 309:8-15.
8Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med, 2002, 347:
9Blaustein MP, Robinson SW, Gottlieb SS, et al. Sex, digitalis, and the sodium pump. Mol Interv, 2003,3:68-72.
10Ridker PM, Cook NR, Lee IM, et al. A randomized trail of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Eng J Med, 2005,3529: 1293-1304.
同被引文献8
1陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
2Holbrook AM, Perpira JA, Labiris R, et al. Systemiatic overview of warfarin and its drug and food interactions[J]. Aach Intern Med,2005,165(10): 1095-1106.
